Synthesis, characterization, and<i>in vivo</i>evaluation of the anticancer activity of a series of 5- and 6-(halomethyl)-2,2′-bipyridine rhenium tricarbonyl complexes-Reference-Cited by-同舟云学术

Synthesis, characterization, andin vivoevaluation of the anticancer activity of a series of 5- and 6-(halomethyl)-2,2′-bipyridine rhenium tricarbonyl complexes

Published:2023 Issue:20 Volume:52 Page:6934-6944
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Nasiri Sovari Sara¹,Kolly Isabelle¹,Schindler Kevin¹^ORCID,Djuric Ana²,Srdic-Rajic Tatjana²,Crochet Aurelien¹^ORCID,Pavic Aleksandar³,Zobi Fabio¹^ORCID

Affiliation:

1. Department of Chemistry, University of Fribourg, Chemin du Musée 10, 1700 Fribourg, Switzerland

2. Department of experimental oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, Beograd, Republic of Serbia

3. Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11000 Belgrade, Republic of Serbia

Abstract

The presence and position of a reactive halomethyl substituent on the diimine ligand system offac-[Re(CO)3]+complexes influences the anticancer activity of the compounds in zebrafish xenografts.

Funder

National Science Foundation

Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/DT/D2DT04041G

Reference73 articles.

1. Cisplatin: The first metal based anticancer drug

2. The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022